Arovella Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.012; its P/E ratio is -9.30; Arovella Therapeutics Limited is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 6.07M	AU$ 6.72M	AU$ 977.47K	AU$ 4.31M	AU$ 98.13K
Total Assets	AU$ 9.21M	AU$ 10.69M	AU$ 6.71M	AU$ 16.25M	AU$ 16.64M
Total Debt	AU$ 144.80K	AU$ 79.23K	AU$ 85.46K	AU$ 53.12K	AU$ 2.05M
Net Debt	AU$ -5.93M	AU$ -6.64M	AU$ -892.01K	AU$ -4.26M	AU$ 1.95M
Total Liabilities	AU$ 1.60M	AU$ 1.71M	AU$ 2.57M	AU$ 2.28M	AU$ 5.18M
Stockholders Equity	AU$ 7.62M	AU$ 8.98M	AU$ 4.14M	AU$ 13.98M	AU$ 11.46M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

Income Statement >

Arovella Therapeutics Limited Debt to Assets

Balance Sheet >

Arovella Therapeutics Limited Cash Flow

Cash Flow >

Arovella Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing